Literature DB >> 19367544

Diagnosis and treatment of demodectic blepharitis.

Tonay Inceboz1, Aylin Yaman, Leyla Over, Arif Taylan Ozturk, Ciler Akisu.   

Abstract

The aim of this study was to investigate the prevalence of Demodex spp. in the eyelash follicles obtained from patients seen in our ophthalmology clinic, to define the symptoms of this infestation, and to examine the effectivity of the therapy. This study was conducted in Department of Ophthalmology and Parasitology, Dokuz Eylül University, School of Medicine. Our study included 82 cases that were seen in the Ophthalmology Department and Parasitology Department for various reasons. We have also observed that the presence of Demodex spp. provokes itching and redness in the eyes and that using baby shampoo for cleansing the face reduces the risk of infestation. After the treatment of 32 cases with 4% pilocarpin HCl gel, we achieved a total cure in 12 eyes (37.5%), partial improvement in 13 eyes (40.6%), (making a total of 25 eyes, 78.1%). The treatment was unsuccessful in 7 eyes (21.9%). In patients with Demodex spp. cleansing with baby shampoo and treating by pilocarpin gel may be used in treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19367544

Source DB:  PubMed          Journal:  Turkiye Parazitol Derg        ISSN: 1300-6320


  3 in total

1.  Prevalence of Demodex folliculorum and Demodex brevis in patients with blepharitis and chalazion.

Authors:  Serife Akkucuk; Ozlem Makbule Kaya; Lokman Aslan; Talat Ozdemir; Ugur Uslu
Journal:  Int Ophthalmol       Date:  2022-10-18       Impact factor: 2.029

2.  Better detection of Demodex mites by Löffler's alkaline methylene blue staining in patients with blepharitis.

Authors:  Katsuji Kiuchi
Journal:  Clin Ophthalmol       Date:  2018-04-16

3.  The Incidence of Demodex folliculorum in the Combination of Allergic Rhinitis and Diabetes Mellitus.

Authors:  Cengiz Arli; Muge Ozsan; Eren Gurkan; Ozlem Aycan Kaya; Sumeyya Kokacya
Journal:  Iran J Parasitol       Date:  2019 Jul-Sep       Impact factor: 1.012

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.